Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1963 Aug;50(2):183–190. doi: 10.1073/pnas.50.2.183

THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES*

Hans J Eggers 1, Edward Reich 1, Igor Tamm 1
PMCID: PMC221150  PMID: 14060635

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALTIMORE D., EGGERS H. J., FRANKLIN R. M., TAMM I. Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. Proc Natl Acad Sci U S A. 1963 Jun;49:843–849. doi: 10.1073/pnas.49.6.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CHOPPIN P. W., EGGERS H. J. Heterogeneity of Coxsackie B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size. Virology. 1962 Nov;18:470–476. doi: 10.1016/0042-6822(62)90037-5. [DOI] [PubMed] [Google Scholar]
  3. CROWTHER D., MELNICK J. L. Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology. 1961 Sep;15:65–74. doi: 10.1016/0042-6822(61)90078-2. [DOI] [PubMed] [Google Scholar]
  4. DARNELL J. E., Jr, EAGLE H. The biosynthesis of poliovirus in cell cultures. Adv Virus Res. 1960;7:1–26. doi: 10.1016/s0065-3527(08)60004-4. [DOI] [PubMed] [Google Scholar]
  5. EAGLE H. Amino acid metabolism in mammalian cell cultures. Science. 1959 Aug 21;130(3373):432–437. doi: 10.1126/science.130.3373.432. [DOI] [PubMed] [Google Scholar]
  6. EGGERS H. J., TAMM I. 2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification. Virology. 1961 Apr;13:545–546. doi: 10.1016/0042-6822(61)90285-9. [DOI] [PubMed] [Google Scholar]
  7. EGGERS H. J., TAMM I. Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med. 1961 Apr 1;113:657–682. doi: 10.1084/jem.113.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LODDO B., FERRARI W., SPANEDDA A., BROTZU G. In vitro guanidino-resistance and guanidino-dependence of poliovirus. Experientia. 1962 Nov 15;18:518–519. doi: 10.1007/BF02151608. [DOI] [PubMed] [Google Scholar]
  9. LODDO B., MUNTONI S., SPANEDDA A., BROTZU G., FERRARI W. Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus. Nature. 1963 Jan 19;197:315–315. doi: 10.1038/197315a0. [DOI] [PubMed] [Google Scholar]
  10. LODDO B. [Inhibition of the multiplication in vitro of poliomyelitis viruses by guanidine. VII. Absence of interference of vitamins, purine and pyrimidine bases in the inhibition by guanidine]. Boll Soc Ital Biol Sper. 1962 Jan 15;38:7–8. [PubMed] [Google Scholar]
  11. RIGHTSEL W. A., DICE J. R., McALPINE R. J., TIMM E. A., McLEAN I. W., Jr, DIXON G. J., SCHABEL F. M., Jr Antiviral effect of guanidine. Science. 1961 Aug 25;134(3478):558–559. doi: 10.1126/science.134.3478.558. [DOI] [PubMed] [Google Scholar]
  12. WECKER E. Effect of puromycin on the replication of Western equine encephalitis and poliomyelitis viruses. Nature. 1963 Mar 30;197:1277–1279. doi: 10.1038/1971277a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES